GPR151
MOLECULAR TARGETG protein-coupled receptor 151
GPR151 (G protein-coupled receptor 151) is targeted by 29 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GPR151
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Tubercidin | 1.39 | 3 |
| 2 | palmidrol [Supplementary Concept] | 1.10 | 2 |
| 3 | Atorvastatin | 0.69 | 1 |
| 4 | Epimedium | 0.69 | 1 |
| 5 | Venlafaxine Hydrochloride | 0.69 | 1 |
| 6 | Allantoin | 0.69 | 1 |
| 7 | alpha-Methyltyrosine | 0.69 | 1 |
| 8 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 9 | Cetylpyridinium Cationic bactericidal surfactant used as | 0.69 | 1 |
| 10 | Chlormadinone Acetate | 0.69 | 1 |
| 11 | Clotrimazole | 0.69 | 1 |
| 12 | cycloserine | 0.69 | 1 |
| 13 | Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. | 0.69 | 1 |
| 14 | Fluspirilene | 0.69 | 1 |
| 15 | Folic Acid | 0.69 | 1 |
| 16 | Gemcitabine | 0.69 | 1 |
| 17 | Methylprednisolone | 0.69 | 1 |
| 18 | Olmesartan Medoxomil | 0.69 | 1 |
| 19 | Ouabain | 0.69 | 1 |
| 20 | Oxytetracycline | 0.69 | 1 |
| 21 | pirenperone | 0.69 | 1 |
| 22 | Promethazine | 0.69 | 1 |
| 23 | Ritodrine | 0.69 | 1 |
| 24 | Tamsulosin | 0.69 | 1 |
| 25 | Tazobactam | 0.69 | 1 |
| 26 | Tilorone | 0.69 | 1 |
| 27 | Tobramycin | 0.69 | 1 |
| 28 | Tolbutamide | 0.69 | 1 |
| 29 | tyrphostin 9 | 0.69 | 1 |
About GPR151 as a Drug Target
GPR151 (G protein-coupled receptor 151) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 29 compounds with documented GPR151 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GPR151 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.